Duchenne Muscular Dystrophy market was valued at US$ 1203 million in 2022 and is anticipated to reach US$ 13540 million by 2029, witnessing a CAGR of 42.1% - Valuates Reports

Duchenne Muscular Dystrophy market was valued at US$ 1203 million in 2022 and is anticipated to reach US$ 13540 million by 2029, witnessing a CAGR of 42.1% during the forecast period 2023-2029.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-12K736/Global_Duchenne_Muscular_Dystrophy_Market_Size_Manufacturers_Supply_Chain_Sales_Channel_and_Clients_2021_2027

uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Duchenne Muscular Dystrophy key players include Sarepta Therapeutics, PTC Therapeutics, etc.
North America is the largest market, with a share over 70%, followed by Europe, and Japan, both have a share over 25 percent.
In terms of product, Exondys 51 is the largest segment, with a share over 55%. And in terms of application, the largest application is Hospitals, followed by Clinics, Home Care, etc.

This report aims to provide a comprehensive presentation of the global market for Duchenne Muscular Dystrophy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duchenne Muscular Dystrophy.
The Duchenne Muscular Dystrophy market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Duchenne Muscular Dystrophy market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Duchenne Muscular Dystrophy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
Exondys 51
Emflaza
Translarna

Segment by Application
Hospitals
Clinics
Home Care

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-12K736/global-duchenne-muscular-dystrophy

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-24O12722/global-duchenne-muscular-dystrophy-dmd-therapeutics

https://reports.valuates.com/market-reports/QYRE-Auto-12K736/global-duchenne-muscular-dystrophy

https://reports.valuates.com/market-reports/QYRE-Auto-0I15683/global-ataluren-api

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

This release was published on openPR.